Cargando…

Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease

The beneficial effects of drugs that act via nicotinic acetylcholine receptors (nAChRs) on Parkinson's disease (PD) symptomatology may explain the negative correlation between cigarette smoking and risk of this neurological condition. Varenicline, an α4β2 nAChR partial agonist approved for smok...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribeiro-Carvalho, A., Leal-Rocha, P.H., Isnardo-Fernandes, J., Araújo, U.C., Abreu-Villaça, Y., Filgueiras, C.C., Manhães, A.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647902/ https://www.ncbi.nlm.nih.gov/pubmed/34878065 http://dx.doi.org/10.1590/1414-431X2021e11679

Ejemplares similares

Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model
por: Dutra-Tavares, Ana Carolina, et al.
Publicado: (2021)

Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice
por: Rodríguez-Vega, Andrés, et al.
Publicado: (2023)

Mood-related behavioral and neurochemical alterations in mice exposed to low chlorpyrifos levels during the brain growth spurt
por: Ribeiro-Carvalho, Anderson, et al.
Publicado: (2020)

Electro-Acupuncture Stimulation Improves Spontaneous Locomotor Hyperactivity in MPTP Intoxicated Mice
por: Wang, Haomin, et al.
Publicado: (2013)

Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)

CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
por: Rocha Santos, Juliana, et al.
Publicado: (2015)

Restoration of intestinal function in an MPTP model of Parkinson’s Disease
por: Ellett, L. J., et al.
Publicado: (2016)

TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease
por: Binukumar, BK, et al.
Publicado: (2016)

Decreased dopamine in striatum and difficult locomotor recovery from MPTP insult after exposure to radiofrequency electromagnetic fields
por: Kim, Ju Hwan, et al.
Publicado: (2019)

Visual hallucinations associated with varenicline: a case report
por: Raidoo, B Mahendri, et al.
Publicado: (2009)

Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons
por: Hong, J, et al.
Publicado: (2015)

Varenicline in the treatment of tobacco dependence
por: Fagerström, Karl, et al.
Publicado: (2008)

Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)

Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline
por: Tonstad, Serena, et al.
Publicado: (2016)

Autotransphntation of the Cervical Sympathetic Ganglion into Monkeys With MPTP-Induced Parkinsonism
por: Itakura, Toru, et al.
Publicado: (1992)

Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2015)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
por: Omar, Noor Azzizah, et al.
Publicado: (2023)

Association of Out-of-Pocket Pharmacy Costs with Adherence to Varenicline
por: Suehs, Brandon T., et al.
Publicado: (2014)

Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015)

The psychiatric effects of varenicline on patients with depression
por: Yeung, EYH, et al.
Publicado: (2015)

Evaluation of the cardiovascular effects of varenicline in rats
por: Selçuk, Engin Burak, et al.
Publicado: (2015)

The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease
por: Mustafa, S., et al.
Publicado: (2016)

Social behavioral changes in MPTP-treated monkey model of Parkinson's disease
por: Durand, Elodie, et al.
Publicado: (2015)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
por: Schwenkgrub, Joanna, et al.
Publicado: (2017)

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
por: Liu, Yingjuan, et al.
Publicado: (2020)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
por: Wianny, Florence, et al.
Publicado: (2017)

Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease
por: Delamarre, Anna, et al.
Publicado: (2020)

Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease
por: Ma, Yuanyuan, et al.
Publicado: (2022)

Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease
por: Tran, Katie K. N., et al.
Publicado: (2022)

GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
por: Fazzari, Maria, et al.
Publicado: (2023)

Cue restricted smoking increases quit rates with varenicline
por: Scholz, Jaqueline R., et al.
Publicado: (2021)

Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study
por: Kotz, Daniel, et al.
Publicado: (2015)

The MPTP Story
por: Langston, J. William
Publicado: (2017)

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
por: Noelker, Carmen, et al.
Publicado: (2013)

Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial
por: Gonzales, D, et al.
Publicado: (2014)

Olfaction in Three Genetic and Two MPTP-Induced Parkinson’s Disease Mouse Models
por: Kurtenbach, Stefan, et al.
Publicado: (2013)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hdhami1vrk8c1cnnp2qq3cp1hc